Reduction of Cystatin B results in increased cathepsin B activity in disomic but not Trisomy 21 human cellular and mouse models.
Down syndrome, resulting from trisomy of human chromosome 21, is a common form of chromosomal disorder that results in intellectual disability and altered risk of several medical conditions. Individuals with Down syndrome have a greatly increased risk of Alzheimer's disease (DSAD), due to the p...
Saved in:
| Main Authors: | Yixing Wu, Karen Cleverley, Frances K Wiseman |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0316822 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The effects of Cstb duplication on APP/amyloid-β pathology and cathepsin B activity in a mouse model.
by: Yixing Wu, et al.
Published: (2021-01-01) -
In silico evaluation of missense SNPs in cancer-associated Cystatin A protein and their potential to disrupt Cathepsin B interaction
by: Shafaat Hossain, et al.
Published: (2025-02-01) -
Biochemical analyses of cystatin-C dimers and cathepsin-B reveals a trypsin-driven feedback mechanism in acute pancreatitis
by: Jana Marielle Modenbach, et al.
Published: (2025-02-01) -
Acute Megakaryoblastic Leukemia with Trisomy 21 and Tetrasomy 21 Clones in a Phenotypically Normal Child with Mosaic Trisomy 21
by: Eric Won, et al.
Published: (2020-01-01) -
Pernicious Anemia in an Adult with Trisomy 21
by: Kentaro Kamada, et al.
Published: (2023-01-01)